Utrecht, Netherlands

Jos Bernard Poell



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jos Bernard Poell: Innovator in MiRNA Research

Introduction

Jos Bernard Poell is a remarkable inventor based in Utrecht, Netherlands, known for his contributions to medical innovations, particularly in the field of miRNA research. With two patents to his name, Poell's work focuses on the diagnostic and therapeutic applications of miRNA in treating conditions such as melanoma and diseases associated with the activated BRAF pathway.

Latest Patents

Poell’s latest patents delve into the diagnostic and therapeutic uses of miRNA molecules. His inventions address diseases and conditions linked to melanoma as well as those associated with the activated BRAF pathway. The core essence of these patents revolves around using miRNA and its equivalents or sources to enhance diagnostic and treatment methodologies for these serious medical conditions.

Career Highlights

Throughout his career, Jos Bernard Poell has been engaged with companies such as Interna Technologies B.V. and Intera Technologies B.V. His innovative work in the realm of miRNA has positioned him as a key figure in advancing therapeutic strategies and improving patient outcomes in oncology.

Collaborations

In his professional journey, Poell has collaborated with talented individuals including Eugene Berezikov and Willemijn Maria Gommans. These collaborations have fostered a rich environment for idea exchange and development, further amplifying the impact of his innovative work.

Conclusion

Jos Bernard Poell stands out as an influential inventor whose notable contributions to miRNA research underline the potential of this area in revolutionizing the treatment of diseases such as melanoma. With his patents and collaborative efforts, Poell continues to be a significant player in the field of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…